EndoCure

Company Overview

Snapshot

Founded in November 2023 by Hadas Ziso and Moshe Shoham, EndoCure operates with 1–10 employees. The company has raised $2.55M across six funding rounds from three investors.

Business overview

EndoCure develops an AI-enabled robotic ultrasound imaging platform, Revealan™, designed to improve the accuracy and consistency of diagnosing chronic conditions like cancer and endometriosis. The platform integrates with existing ultrasound devices to provide operator-agnostic, automated, high-resolution 3D imaging, offering a data density significantly higher than MRI. EndoCure targets the healthcare and medical devices industries, aiming to enhance early detection and reliable follow-ups for small findings, ultimately optimizing patient outcomes.

Strategic signal

In January 2026, EndoCure was highlighted for its robotic platform capable of producing 3D images with 10 times the density of an MRI, led by a repeat founder and a world-renowned robotics pioneer. This signals a significant advancement in medical imaging, potentially offering a more reliable and accessible diagnostic tool for conditions often missed by current methods, and validating the company's technological leadership in the health tech sector.

Company Intelligence Q&A

What is EndoCure's core technology?

EndoCure's core technology is Revealan™, a robotic ultrasound imaging platform that integrates with off-the-shelf ultrasound devices to provide operator-agnostic, automated, AI-enabled, high-resolution 3D imaging. This technology produces medical images with a density 10 times higher than that of an MRI.

When was EndoCure founded and by whom?

EndoCure was founded in November 2023 by co-founders Hadas Ziso and Moshe Shoham.

What significant recognition did EndoCure receive in November 2023?

In November 2023, EndoCure was selected as a TOP12 finalist at the MEDICA STARTUP COMPETITION, chosen from 280 submissions.

What is the primary problem EndoCure aims to solve?

EndoCure aims to address the limitations of current imaging tools in accurately diagnosing chronic conditions like cancer and endometriosis, where misdiagnosis is common due to the operator-dependent and inconsistent nature of existing ultrasound technology.